Literature DB >> 12169218

Prevention of Alzheimer's disease: where we stand.

Mary Sano1.   

Abstract

Alzheimer's disease has been recognized as a major public health issue that will grow in prominence as life expectancy increases and as the shape of population demographics shifts toward expansion in the older age ranges with contraction in younger ages. The magnitude of the problem can be expressed in incidence, prevalence economics, and quality of life. Great strides have been made in understanding and treating this disease, but current clinical management is far from satisfactory and progression seems inevitable once the disease is diagnosed. Such forces in any disease encourage intervention strategies to move from treatment to prevention. However, this vision can only be met with reasonable success when pathology is understood and there is evidence that manipulation of that pathology leads to clinical benefit. This is the challenge that lies ahead to achieve the goal of prevention of Alzheimer's disease. This review begins by examining the progress that has been made in this disease. Current efforts to develop prevention strategies are described and possible agents for future evaluation are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169218     DOI: 10.1007/s11910-002-0064-8

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  63 in total

1.  A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.

Authors:  P L Le Bars; M M Katz; N Berman; T M Itil; A M Freedman; A F Schatzberg
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

2.  Anti-inflammatory drugs and Alzheimer disease.

Authors:  P L McGeer; E McGeer; J Rogers; J Sibley
Journal:  Lancet       Date:  1990-04-28       Impact factor: 79.321

3.  Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain.

Authors:  S S Petanceska; V Nagy; D Frail; S Gandy
Journal:  Exp Gerontol       Date:  2000-12       Impact factor: 4.032

4.  Double placebo design in a prevention trial for Alzheimer's disease.

Authors:  Barbara K Martin; Curtis L Meinert; John C S Breitner
Journal:  Control Clin Trials       Date:  2002-02

5.  Statins and the risk of dementia.

Authors:  H Jick; G L Zornberg; S S Jick; S Seshadri; D A Drachman
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

6.  Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.

Authors:  R A Mulnard; C W Cotman; C Kawas; C H van Dyck; M Sano; R Doody; E Koss; E Pfeiffer; S Jin; A Gamst; M Grundman; R Thomas; L J Thal
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

7.  Hyperhomocysteinaemia--a common finding in a psychogeriatric population.

Authors:  K Nilsson; L Gustafson; R Fäldt; A Andersson; L Brattström; A Lindgren; B Israelsson; B Hultberg
Journal:  Eur J Clin Invest       Date:  1996-10       Impact factor: 4.686

8.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  M Sano; C Ernesto; R G Thomas; M R Klauber; K Schafer; M Grundman; P Woodbury; J Growdon; C W Cotman; E Pfeiffer; L S Schneider; L J Thal
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

9.  Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain.

Authors:  C D Toran-Allerand; R C Miranda; W D Bentham; F Sohrabji; T J Brown; R B Hochberg; N J MacLusky
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

10.  Increased density of cortical apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol.

Authors:  D L Sparks; H Liu; D R Gross; S W Scheff
Journal:  Neurosci Lett       Date:  1995-03-03       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.